Login Register Cart 0
Generic placeholder image

Current Neurovascular Research

Editor-in-Chief

ISSN (Print): 1567-2026
ISSN (Online): 1875-5739

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Dexmedetomidine Pretreatment Improves Lipopolysaccharide-induced Iron Homeostasis Disorder in Aged Mice

Author(s): Fenghui Guo, Jinmeng Kang, Juntao Tan, Yong Wang, Li Jia and Hongmeng Xu*

Volume 17, Issue 2, 2020

Page: [164 - 170] Pages: 7

DOI: 10.2174/1567202617666200217105109

Price: $65

Abstract

Background: Iron homeostasis disorder and neuroinflammation are the most commonly known factors that promote the occurrence and development of cognitive impairment in people. Dexmedetomidine has an anti-inflammatory effect, and it reduces the incidence of postoperative cognitive dysfunction. Therefore, the aim of this study is to verify whether dexmedetomidine could improve lipopolysaccharide-induced iron homeostasis disorder in aged mice, and show neuroprotective effect.

Methods: First part, forty 12 month old male Kunming(KM) mice were divided into group N and group D: Normal saline group (group N), Dexmedetomidine group (group D). Second part, sixty 12-month-old male KM mice were divided into the following three groups: Normal saline group (group N), Lipopolysaccharide group (group LPS) and Dexmedetomidine + Lipopolysaccharide group (group D + LPS). The mice in group D + LPS were given dexmedetomidine, and given LPS intraperitoneally 2 h later. Mice underwent an oriented navigation test and a space exploration test in the Morris Water maze (MWM) test. The expression levels of Interleukin-6 ( IL-6), L-ferritin (FTL) and Transferrin receptor-1 (TfR1) in hippocampus were detected by the Western blot analysis; the hippocampal hepcidin mRNA was detected by Real-time PCR(RT-PCR); the reactive oxygen species (ROS) in the hippocampus was measured using ROS test kit.

Results: Dexmedetomidine improved the cognitive decline induced by LPS. Dexmedetomidine reduced the level of hippocampal IL-6, and it attenuated the increase in their levels caused by LPS. It had no effect on hippocampal hepcidin mRNA, FTL, TfR1 and ROS but it could attenuate the increase caused by LPS.

Conclusion: Dexmedetomidine has no effect on iron metabolism pathway, but it can improve the cognitive decline and the iron disorder by reducing neuroinflammation and oxidative stress. The research indicates that dexmedetomidine plays a neuroprotective role.

Keywords: Dexmedetomidine, iron, lipopolysaccharide, mice, neuroinflammation, cognitive.

« Previous Next »
[1]
Feinkohl I, Winterer G, Spies CD, Pischon T. Cognitive reserve and the risk of postoperative cognitive dysfunction. Dtsch Arztebl Int 2017; 114(7): 110-7.
[PMID: 28302254]
[2]
Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L. The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol 2014; 13(10): 1045-60.
[http://dx.doi.org/10.1016/S1474-4422(14)70117-6] [PMID: 25231526]
[3]
Muhoberac BB, Vidal R. Iron, Ferritin, hereditary ferritinopathy, and neurodegeneration. Front Neurosci 2019; 13: 1195.
[http://dx.doi.org/10.3389/fnins.2019.01195] [PMID: 31920471]
[4]
Gaasch JA, Lockman PR, Geldenhuys WJ, Allen DD, Van der Schyf CJ. Brain iron toxicity: differential responses of astrocytes, neurons, and endothelial cells. Neurochem Res 2007; 32(7): 1196-208.
[http://dx.doi.org/10.1007/s11064-007-9290-4] [PMID: 17404839]
[5]
Sripetchwandee J, Pipatpiboon N, Chattipakorn N, Chattipakorn S. Combined therapy of iron chelator and antioxidant completely restores brain dysfunction induced by iron toxicity. PLoS One 2014; 9(1), e85115.
[http://dx.doi.org/10.1371/journal.pone.0085115] [PMID: 24400127]
[6]
Chaitanya G, Arivazhagan A, Sinha S, et al. Dexmedetomidine anesthesia enhances spike generation during intra-operative electrocorticography: A promising adjunct for epilepsy surgery. Epilepsy Res 2015; 109: 65-71.
[http://dx.doi.org/10.1016/j.eplepsyres.2014.10.006] [PMID: 25524844]
[7]
Xi C, Sun S, Pan C, Ji F, Cui X, Li T. Different effects of propofol and dexmedetomidine sedation on electroencephalogram patterns: Wakefulness, moderate sedation, deep sedation and recovery. PLoS One 2018; 13(6), e0199120.
[http://dx.doi.org/10.1371/journal.pone.0199120] [PMID: 29920532]
[8]
Zhou C, Zhu Y, Liu Z, Ruan L. Effect of dexmedetomidine on postoperative cognitive dysfunction in elderly patients after general anaesthesia: A meta-analysis. J Int Med Res 2016; 44(6): 1182-90.
[http://dx.doi.org/10.1177/0300060516671623] [PMID: 27913743]
[9]
Yang W, Kong LS, Zhu XX, Wang RX, Liu Y, Chen LR. Effect of dexmedetomidine on postoperative cognitive dysfunction and inflammation in patients after general anaesthesia: A PRISMA compliant systematic review and meta-analysis. Medicine (Baltimore) 2019; 98(18), e15383.
[http://dx.doi.org/10.1097/MD.0000000000015383] [PMID: 31045788]
[10]
Heneka MT, Carson MJ, El Khoury J, et al. Neuroinflammation in Alzheimer’s disease. Lancet Neurol 2015; 14(4): 388-405.
[http://dx.doi.org/10.1016/S1474-4422(15)70016-5] [PMID: 25792098]
[11]
Alam A, Hana Z, Jin Z, Suen KC, Ma D. Surgery, neuroinflammation and cognitive impairment. EBioMedicine 2018; 37: 547-56.
[http://dx.doi.org/10.1016/j.ebiom.2018.10.021] [PMID: 30348620]
[12]
Cao Y, Li Z, Ma L, et al. Isoflurane induced postoperative cognitive dysfunction is mediated by hypoxia inducible factor 1α dependent neuroinflammation in aged rats. Mol Med Rep 2018; 17(6): 7730-6.
[http://dx.doi.org/10.3892/mmr.2018.8850] [PMID: 29620198]
[13]
Tang JX, Baranov D, Hammond M, Shaw LM, Eckenhoff MF, Eckenhoff RG. Human Alzheimer and inflammation biomarkers after anesthesia and surgery. Anesthesiology 2011; 115(4): 727-32.
[http://dx.doi.org/10.1097/ALN.0b013e31822e9306] [PMID: 21857497]
[14]
Peng M, Wang YL, Wang CY, Chen C. Dexmedetomidine attenuates lipopolysaccharide-induced proinflammatory response in primary microglia. J Surg Res 2013; 179(1): e219-25.
[http://dx.doi.org/10.1016/j.jss.2012.05.047] [PMID: 22683080]
[15]
Yeh CH, Hsieh LP, Lin MC, et al. Dexmedetomidine reduces lipopolysaccharide induced neuroinflammation, sickness behavior, and anhedonia. PLoS One 2018; 13(1), e0191070.
[http://dx.doi.org/10.1371/journal.pone.0191070] [PMID: 29351316]
[16]
Yarjanli Z, Ghaedi K, Esmaeili A, Rahgozar S, Zarrabi A. Iron oxide nanoparticles may damage to the neural tissue through iron accumulation, oxidative stress, and protein aggregation. BMC Neurosci 2017; 18(1): 51.
[http://dx.doi.org/10.1186/s12868-017-0369-9] [PMID: 28651647]
[17]
Agrawal S, Berggren KL, Marks E, Fox JH. Impact of high iron intake on cognition and neurodegeneration in humans and in animal models: A systematic review. Nutr Rev 2017; 75(6): 456-70.
[http://dx.doi.org/10.1093/nutrit/nux015] [PMID: 28505363]
[18]
Pan K, Li X, Chen Y, et al. Deferoxamine pre-treatment protects against postoperative cognitive dysfunction of aged rats by depressing microglial activation via ameliorating iron accumulation in hippocampus. Neuropharmacology 2016; 111: 180-94.
[http://dx.doi.org/10.1016/j.neuropharm.2016.09.004] [PMID: 27608977]
[19]
Li Y, Pan K, Chen L, et al. Deferoxamine regulates neuroinflammation and iron homeostasis in a mouse model of postoperative cognitive dysfunction. J Neuroinflam 2016; 13(1): 268.
[http://dx.doi.org/10.1186/s12974-016-0740-2] [PMID: 27733186]
[20]
Pietsch EC, Chan JY, Torti FM, Torti SV. Nrf2 mediates the induction of ferritin H in response to xenobiotics and cancer chemopreventive dithiolethiones. J Biol Chem 2003; 278(4): 2361-9.
[http://dx.doi.org/10.1074/jbc.M210664200] [PMID: 12435735]
[21]
Connor JR, Snyder BS, Arosio P, Loeffler DA, LeWitt P. A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer’s diseased brains. J Neurochem 1995; 65(2): 717-24.
[http://dx.doi.org/10.1046/j.1471-4159.1995.65020717.x] [PMID: 7616228]
[22]
Kaur D, Rajagopalan S, Andersen JK. Chronic expression of Hferritin in dopaminergic midbrain neurons results in an age-related expansion of the labile iron pool and subsequent neurodegeneration: Implications for Parkinson’s disease. Brain Res 2009; 1297: 17-22.
[http://dx.doi.org/10.1016/j.brainres.2009.08.043] [PMID: 19699718]
[23]
An LN, Yue Y, Guo WZ, et al. Surgical trauma induces iron accumulation and oxidative stress in a rodent model of postoperative cognitive dysfunction. Biol Trace Elem Res 2013; 151(2): 277-83.
[http://dx.doi.org/10.1007/s12011-012-9564-9] [PMID: 23229539]
[24]
Du F, Qian C, Qian ZM, et al. Hepcidin directly inhibits transferrin receptor 1 expression in astrocytes via a cyclic AMP-protein kinase A pathway. Glia 2011; 59(6): 936-45.
[http://dx.doi.org/10.1002/glia.21166] [PMID: 21438013]
[25]
Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420(6917): 885-91.
[http://dx.doi.org/10.1038/nature01326] [PMID: 12490963]
[26]
Ding H, Yan CZ, Shi H, et al. Hepcidin is involved in iron regulation in the ischemic brain. PLoS One 2011; 6(9)e25324
[http://dx.doi.org/10.1371/journal.pone.0025324] [PMID: 21957487]
[27]
Urrutia P, Aguirre P, Esparza A, et al. Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells. J Neurochem 2013; 126(4): 541-9.
[http://dx.doi.org/10.1111/jnc.12244] [PMID: 23506423]
[28]
Tasdogan M, Memis D, Sut N, Yuksel M. Results of a pilot study on the effects of propofol and dexmedetomidine on inflammatory responses and intraabdominal pressure in severe sepsis. J Clin Anesth 2009; 21(6): 394-400.
[http://dx.doi.org/10.1016/j.jclinane.2008.10.010] [PMID: 19833271]
[29]
Pandharipande PP, Sanders RD, Girard TD, et al. Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. Crit Care 2010; 14(2): R38.
[http://dx.doi.org/10.1186/cc8916] [PMID: 20233428]
[30]
Wu Y, Liu Y, Huang H, et al. Dexmedetomidine inhibits inflammatory reaction in lung tissues of septic rats by suppressing TLR4/NF-κB pathway. Mediators Inflamm 2013; 2013562154
[http://dx.doi.org/10.1155/2013/562154] [PMID: 23690665]
[31]
Liu Y, Ma L, Gao M, Guo W, Ma Y. Dexmedetomidine reduces postoperative delirium after joint replacement in elderly patients with mild cognitive impairment. Aging Clin Exp Res 2016; 28(4): 729-36.
[http://dx.doi.org/10.1007/s40520-015-0492-3] [PMID: 26559412]
[32]
Li WX, Luo RY, Chen C, et al. Effects of propofol, dexmedetomidine, and midazolam on postoperative cognitive dysfunction in elderly patients: A randomized controlled preliminary trial. Chin Med J (Engl) 2019; 132(4): 437-45.
[http://dx.doi.org/10.1097/CM9.0000000000000098] [PMID: 30707179]

Rights & Permissions Print Cite
Article Metrics
47
1
© 2024 Bentham Science Publishers | Privacy Policy